Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
60,307,130
-
Shares change
-
+11,811,452
-
Total reported value, excl. options
-
$875,021,915
-
Value change
-
+$158,173,274
-
Put/Call ratio
-
92%
-
Number of buys
-
68
-
Number of sells
-
-46
-
Price
-
$14.51
Significant Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q1 2020
162 filings reported holding AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value as of Q1 2020.
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60,307,130 shares
of 130,702,820 outstanding shares and own 46% of the company stock.
Largest 10 shareholders include HealthCor Management, L.P. (9,763,920 shares), FMR LLC (7,972,758 shares), Consonance Capital Management LP (6,909,374 shares), NEA Management Company, LLC (5,172,683 shares), Point72 Asset Management, L.P. (4,669,343 shares), Avoro Capital Advisors LLC (1,725,000 shares), BAKER BROS. ADVISORS LP (1,701,929 shares), PICTET ASSET MANAGEMENT LTD (1,615,882 shares), RENAISSANCE TECHNOLOGIES LLC (1,438,800 shares), and ORBIMED ADVISORS LLC (1,336,547 shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.